These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3681441)

  • 1. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
    Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
    J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR; Wilf LH
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible use of radioiodinated metaiodobenzylguanidine (MIBG) in medullary thyroid carcinoma.
    Troncone L; Rufini V; Maussier ML; Valenza V; Montemaggi P; Legnaioli M
    Thyroidology; 1988 Apr; (1):45-53. PubMed ID: 2484894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
    Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
    Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of [131I]metaiodobenzylguanidine in the treatment of medullary thyroid carcinoma: results in five cases.
    Troncone L; Rufini V; Maussier ML; Valenza V; Daidone MS; Luzi S; De Santis M
    J Nucl Biol Med (1991); 1991; 35(4):327-31. PubMed ID: 1823849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
    Ahuja S; Koppenhagen K; Ernst H
    Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
    Troncone L; Rufini V; Montemaggi P; Danza FM; Lasorella A; Mastrangelo R
    Eur J Nucl Med; 1990; 16(4-6):325-35. PubMed ID: 2351179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I]metaiodobenzylguanidine therapy in medullary thyroid cancer: Guy's Hospital experience.
    Clarke SE
    J Nucl Biol Med (1991); 1991; 35(4):323-6. PubMed ID: 1823848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.
    Lupoli G; Lombardi G; Panza N; Biondi B; Pacilio G; Lastoria S; Salvatore M
    Med Oncol Tumor Pharmacother; 1991; 8(1):7-13. PubMed ID: 2041383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I]metaiodobenzylguanidine treatment of a malignant paraganglioma.
    Baulieu JL; Guilloteau D; Calais G; Lefloch O; Besnard JC
    J Nucl Biol Med (1991); 1991; 35(4):313-4. PubMed ID: 1823844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidine.
    Guilloteau D; Baulieu JL; Besnard JC
    Eur J Nucl Med; 1985; 11(6-7):198-200. PubMed ID: 4076227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.